Showing 61 - 80 results of 124 for search '"Ted ', query time: 0.06s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72

    The relationship between cholesterol levels and thyroid eye disease by Caroline Cardo, Roberto Bernardo Santos, Ana Beatriz Pinotti Pedro Miklos, Sabrina Barbosa Jaconis, João Hamilton Romaldini, Danilo Villagelin

    Published 2025-02-01
    “…Background: Thyroid eye disease (TED) is the most prevalent extrathyroidal manifestation of Graves’ disease (GD). …”
    Get full text
    Article
  13. 73

    Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease by Nami Suzuki, Jaeduk Yoshimura Noh, Ai Kozaki, Natsuko Watanabe, Ai Yoshihara, Miho Fukushita, Masako Matsumoto, Hideyuki Imai, Shigenori Hiruma, Masahiro Ichikawa, Masakazu Koshibu, Akiko Sankoda, Rei Hirose, Toshu Inoue, Kiminori Sugino, Koichi Ito

    Published 2025-01-01
    “…The active phase TED was observed in 8 of the 72 patients. Of the 72 patients newly diagnosed with TED in postpartum, two-thirds were accompanied by thyroid dysfunction and 8 of them were in active phase.…”
    Get full text
    Article
  14. 74

    A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with acti... by Hao Zhang, Weimin He

    Published 2025-01-01
    “…A total of 156 eligible patients were selected from the TED patient database of the Ophthalmology Department of West China Hospital of Sichuan University. …”
    Get full text
    Article
  15. 75

    A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context by Yuji Hiromatsu, Eri Ishikawa, Ai Kozaki, Yasuhiro Takahashi, Mika Tanabe, Ken Hayashi, Yukihiro Imagawa, Kazutoyo Kaneda, Masashi Mimura, Xiaoxian Dai, Tomoko Hayashida, Takashi Akamizu

    Published 2025-02-01
    “…Main inclusion criteria were as follows: age 20–80 years; Graves’ disease, in a euthyroid or mild hypo/hyperthyroid state; clinical activity score (CAS) ≥3; moderate-to-severe TED; ≥3-mm increase in proptosis before TED onset and/or proptosis ≥18 mm at baseline; and TED duration ≤9 months. …”
    Get full text
    Article
  16. 76

    Transition from hypothyroidism to Graves’ disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration o... by Koichiro Mizuochi, Yuji Hiromatsu, Yui Nakamura, Aya Sonezaki, Ayaka Adachi, Tamotsu Kato, Nobuhiko Wada, Tomohiro Kurose, Shiho Watanabe

    Published 2025-01-01
    “…A 55-year-old woman transitioned from hypothyroidism to Graves’ disease (GD) and then developed thyroid eye disease (TED) with proptosis and diplopia. After three cycles of daily methylprednisolone pulse therapy, her condition progressed to dysthyroid optic neuropathy with decreased visual acuity in both eyes. …”
    Get full text
    Article
  17. 77

    Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease by Kyung In Woo, Suk-Woo Yang, Jeong Kyu Lee, Sang In Khwarg, Jin Sook Yoon, Sehyun Baek, Jae Wook Yang, JaeSang Ko, Koung Hoon Kook, Sang Duck Kim, Jun Hyuk Son, Helen Lew, Sung Bok Lee, Jae Woo Jang, Hee Young Choi, Mi Jung Chi

    Published 2022-06-01
    “…Objectives The clinical course of thyroid eye disease (TED) is heterogeneous and predicting patients who may develop the severe sequelae of the disease is difficult. …”
    Get full text
    Article
  18. 78

    TOM500: A Multi-Organ Annotated Orbital MRI Dataset for Thyroid Eye Disease by Haiyang Zhang, Hoi Chi Chan, Jiashuo Xu, Mengda Jiang, Xiaofeng Tao, Huifang Zhou, Xuefei Song, Xianqun Fan

    Published 2025-01-01
    “…It includes clinical data, T2-weighted MRI scans, and corresponding segmentations from 500 patients with thyroid eye disease (TED) during their initial visit. TED is a common autoimmune disorder with distinct orbital MRI features. …”
    Get full text
    Article
  19. 79

    Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab by Oscar Otero-Marquez, Mona Fayad, Alexander Pinhas, Toco Y. P. Chui, Richard B. Rosen, Harsha S. Reddy

    Published 2022-01-01
    “…We examined the variation of parafoveal surface macrophages in a thyroid eye disease (TED) patient before and after treatment with teprotumumab (Tepezza, Horizon therapeutics). …”
    Get full text
    Article
  20. 80

    Health and Safety for You / by Diehl, Harold S. (Harold Sheely), 1891-1973

    Published 1980
    View in OPAC
    Book